Foghorn Therapeutics
FHTX
#9648
Rank
โ‚ฌ94.01 M
Marketcap
1,57ย โ‚ฌ
Share price
-3.37%
Change (1 day)
-60.91%
Change (1 year)

EPS for Foghorn Therapeutics (FHTX)

EPS in 2026 (TTM): -0,79ย โ‚ฌ

According to Foghorn Therapeutics's latest financial reports the company's current EPS (TTM) is -0,84ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,08ย โ‚ฌ an increase over its 2024 EPS that were of -1,44ย โ‚ฌ.

EPS history for Foghorn Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,79ย โ‚ฌ-26.68%
2025-1,08ย โ‚ฌ-25.32%
2024-1,44ย โ‚ฌ-32.48%
2023-2,13ย โ‚ฌ-10.69%
2022-2,39ย โ‚ฌ-4.03%
2021-2,49ย โ‚ฌ-56.18%
2020-5,68ย โ‚ฌ169.62%
2019-2,11ย โ‚ฌ72.21%
2018-1,22ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 46.74%๐Ÿ‡บ๐Ÿ‡ธ USA